Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Midstream Corp

28.08
+0.83003.05%
Post-market: 28.080.00000.00%16:05 EDT
Volume:65.01K
Turnover:1.81M
Market Cap:340.35M
PE:-2.11
High:28.59
Open:27.53
Low:26.98
Close:27.25
Loading ...

Summit Midstream Corporation Announces the Acquisition of Moonrise Midstream and Provides DJ Basin Operational Update

PR Newswire
·
10 Mar

SMC Corporation Completes Share Repurchase

TIPRANKS
·
03 Mar

TPG Telecom's Post-Paid Weakness Concerns Bears -- Market Talk

Dow Jones
·
03 Mar

Summit Midstream Corporation Announces Resumption of Preferred Dividend in First Quarter 2025

THOMSON REUTERS
·
28 Feb

Press Release: Summit Midstream Corporation Announces Resumption of Preferred Dividend in First Quarter 2025

Dow Jones
·
28 Feb

SMC Global Securities Board Approves INR1.5 Billion Debt Issue

MT Newswires Live
·
28 Feb

Investing in Summit Midstream (NYSE:SMC) three years ago would have delivered you a 151% gain

Simply Wall St.
·
22 Feb

SMC Global Securities' Chief Risk Officer Dies

MT Newswires Live
·
18 Feb

Police aiming for 2 election rally sites for each GRC, 1 for each SMC

CNA
·
18 Feb

Jefferies Keeps Their Hold Rating on SMC (OR) (SMECF)

TIPRANKS
·
17 Feb

Jefferies Adjusts SMC's Price Target to 53,500 Yen From 58,800 Yen, Keeps at Hold

MT Newswires Live
·
17 Feb

SMC's Profit Fell Over 12% in Fiscal Nine Months

MT Newswires Live
·
17 Feb

Inflationary NZ super-for-housing scheme a warning on Dutton’s election pitch

Sydney Morning Herald
·
15 Feb

SMC Q3 GAAP EPS $0.22, Same YoY, Sales $1.28B Up From $1.28B YoY

Benzinga
·
14 Feb

SMC Corp 9-Mos Net Y120.38B Vs Net Y137.30B

Dow Jones
·
14 Feb

Jefferies Adjusts SMC's Price Target to 58,800 Yen From 65,000 Yen, Keeps at Hold

MT Newswires Live
·
10 Feb

3-year suspension for psychiatrist who prescribed medication beyond maximum dosage

CNA
·
05 Feb

PRophet Integrates Influencer Discovery Feature within 'Taylor', its AI-powered Journalist Discovery and Content Creation Product

PR Newswire
·
30 Jan

SMC Global Securities Appoints COO

MT Newswires Live
·
30 Jan

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium

GlobeNewswire
·
24 Jan